| Name | Title | Contact Details |
|---|
Abbott Home Health Care Inc is a Stoughton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Established in 1968, Providence Community Health Centers, Inc. is the largest primary health care provider in Providence, Rhode Island. In addition to eight health centers, we also operate a school-based program, and a dental clinic serving children under the age of 19 and pregnant women. PCHC is a non-profit health care organization and the only Federally Qualified Heath Center (FQHC) in Providence. We have recruited some of the area`s most prestigious physicians and empowered them to make a difference providing quality care to more than 50,000+ residents of Providence and its surrounding areas. As we continue to grow our network of neighborhood-based clinics, PCHC is seeking physicians to join our team. Our services include: Family Practice, Internal Medicine, Pediatrics, Obstetrics, Gynecology, Behavioral Health, Dental Care and Express Care (urgent care) alongside with selected specialty services.
NDI Medical is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Beachwood, OH. To find more information about NDI Medical, please visit www.ndimedical.com
Affinity Health Plan is an independent, not-for-profit organization offering low cost, quality health care coverage to underserved New Yorkers. Its programs are sponsored by New York State and include Child Health Plus, Family Health Plus, Medicaid managed care, and Medicare. Founded in 1986, Affinity serves more than 275,000 members in New York City, Long Island, and the surrounding counties of Westchester, Rockland and Orange.
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.